Blastenkrise der chronischen myeloischen Leukämie: Ergebnisse mit Vindesin-Prednisolon

Autor: Nitsche D, Tschurtschenthaler G, G. Michlmayr, M. Stöger

Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 110:1936-1939

Nine patients with blast crises of chronic myeloid leukaemia were treated with a combination of vindesine and prednisolone. Vindesine, 2 mg/m2, was administered intravenously on two successive days each week and prednisolone, 60 mg/m2, orally once da

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ee66ba74b7adb9f87dc0926cf977ec9
https://doi.org/10.1055/s-2008-1069116

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clarithromycin-Therapie eines B-Zell-MALT-Lymphoms. (German)

Autor: Danilko, L., Haas, K., Schönherr, U., Tschurtschenthaler, G.

Publikováno v: Der Ophthalmologe; May2013, Vol. 110 Issue 5, p447-450, 4p

Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.

Autor: Johansson P; Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany., Bergmann A; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany., Rahmann S; Genome Informatics, Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Wohlers I; Genome Informatics, Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Scholtysik R; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany., Przekopowitz M; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany., Seifert M; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany., Tschurtschenthaler G; Laboratory for Molecular Biology and Tumor Cytogenetics, Department of Haematology and Oncology, Linz, Austria., Webersinke G; Laboratory for Molecular Biology and Tumor Cytogenetics, Department of Haematology and Oncology, Linz, Austria., Jäger U; Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Siebert R; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany., Klein-Hitpass L; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany., Dührsen U; Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Dürig J; Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Küppers R; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.

Publikováno v: International journal of cancer [Int J Cancer] 2016 Jan 01; Vol. 138 (1), pp. 121-4. Date of Electronic Publication: 2015 Jul 30.